Publisher
Springer Science and Business Media LLC
Subject
Molecular Biology,Applied Microbiology and Biotechnology,Biochemistry,Bioengineering,Biotechnology
Reference48 articles.
1. Cavasotto, C. N., & Di Filippo, J. I. (2021). In silico drug repurposing for COVID-19: targeting SARS-CoV-2 proteins through docking and consensus ranking. Molecular Informatics, 40(1), 2000115.
2. Hui, D. S., Azhar, E. I., Madani, T. A., Ntoumi, F., Kock, R., Dar, O., & Petersen, E. (2020). The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health—The latest 2019 novel coronavirus outbreak in Wuhan, China. International Journal of Infectious Diseases, 91, 264–266.
3. Zhang, L., Lin, D., Sun, X., Curth, U., Drosten, C., Sauerhering, L., & Hilgenfeld, R. (2020). Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors. Science, 368(6489), 409–412.
4. Shalayel, M. H., Al-Mazaideh, G. M., Aladaileh, S. H., Al-Swailmi, F. K., & Al-Thiabat, M. G. (2020). Vitamin D is a potential inhibitor of COVID-19: In silico molecular docking to the binding site of SARS-CoV-2 endoribonuclease Nsp15. Pakistan Journal of Pharmaceutical Sciences, 33(5), 2179–2186.
5. Kim, Y., Jedrzejczak, R., Maltseva, N. I., Wilamowski, M., Endres, M., Godzik, A., & Joachimiak, A. (2020). Crystal structure of Nsp15 endoribonuclease NendoU from SARS-CoV-2. Protein Science, 29(7), 1596–1605.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献